Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society

Abstract Objective To develop evidence‐based recommendations to guide the surgical management and postoperative follow‐up of adults with primary hyperparathyroidism. Methods Representatives from relevant Australian and New Zealand Societies used a systematic approach for adaptation of guidelines (ADAPTE) to derive an evidence‐informed position statement addressing eight key questions. Results Diagnostic imaging does not determine suitability for surgery but can guide the planning of surgery in suitable candidates. First‐line imaging includes ultrasound and either parathyroid 4DCT or scintigraphy, depending on local availability and expertise. Minimally invasive parathyroidectomy is appropriate in most patients with concordant imaging. Bilateral neck exploration should be considered in those with discordant/negative imaging findings, multi‐gland disease and genetic/familial risk factors. Parathyroid surgery, especially re‐operative surgery, has better outcomes in the hands of higher volume surgeons. Neuromonitoring is generally not required for initial surgery but should be considered for re‐operative surgery. Following parathyroidectomy, calcium and parathyroid hormone levels should be re‐checked in the first 24 h and repeated early if there are risk factors for hypocalcaemia. Eucalcaemia at 6 months is consistent with surgical cure; parathyroid hormone levels do not need to be re‐checked in the absence of other clinical indications. Longer‐term surveillance of skeletal health is recommended. Conclusions This position statement provides up‐to‐date guidance on evidence‐based best practice surgical and postoperative management of adults with primary hyperparathyroidism.